PERCEPTIVE ADVISORS LLC Insider Trading $LYRA Lyra Therapeutics, Inc.
Get free email notifications about insider trading for PERCEPTIVE ADVISORS LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of PERCEPTIVE ADVISORS LLC. PERCEPTIVE ADVISORS LLC is 10% Owner in LA JOLLA PHARMACEUTICAL CO ($LJPC) and 10% Owner in VBI VACCINES INC. ($VBIV) and in AMICUS THERAPEUTICS INC ($FOLD) and 10% Owner in AMICUS THERAPEUTICS INC ($FOLD) and 10% Owner in SCYNEXIS INC ($SCYX) and in AGILE THERAPEUTICS INC ($AGRX) and 10% Owner in AGILE THERAPEUTICS INC ($AGRX) and 10% Owner in Athenex, Inc. ($ATNX) and 10% Owner in ALBIREO PHARMA, INC. ($ALBO) and Director in Lyra Therapeutics, Inc. ($LYRA) and 10% Owner in VBI Vaccines Inc/BC ($VBIV) and 10% Owner in Aldeyra Therapeutics, Inc. ($ALDX) and 10% Owner in ADMA BIOLOGICS, INC. ($ADMA) and 10% Owner in ZOGENIX, INC. ($ZGNX) and 10% Owner in ACELRX PHARMACEUTICALS INC ($ACRX) and Director in CATABASIS PHARMACEUTICALS INC ($CATB) and 10% Owner in LEAP THERAPEUTICS, INC. ($LPTX) and 10% Owner in Versartis, Inc. ($VSAR) and in Kadmon Holdings, Inc. ($KDMN) and 10% Owner in Menlo Therapeutics Inc. ($MNLO) and 10% Owner in Corium International, Inc. ($CORI) and 10% Owner in Quotient Ltd ($QTNT) and 10% Owner in Athira Pharma, Inc. ($ATHA) and Director in Athira Pharma, Inc. ($ATHA) and 10% Owner in Global Blood Therapeutics, Inc. ($GBT) and 10% Owner in Verrica Pharmaceuticals Inc. ($VRCA) and 10% Owner in Crinetics Pharmaceuticals, Inc. ($CRNX) and Director in Crinetics Pharmaceuticals, Inc. ($CRNX) and 10% Owner in Dova Pharmaceuticals, Inc. ($DOVA) and 10% Owner in Motus GI Holdings, Inc. ($MOTS) and 10% Owner in Prometheus Biosciences, Inc. ($RXDX) and 10% Owner in Rain Therapeutics Inc. ($RAIN) and Director in Solid Biosciences Inc. ($SLDB) and Director in MeiraGTx Holdings plc ($MGTX) and Director in Landos Biopharma, Inc. ($LABP) and Director in ARYA Sciences Acquisition Corp II ($ARYB).
PERCEPTIVE ADVISORS LLC in Lyra Therapeutics, Inc.
Trading Symbol: LYRAIndustry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of PERCEPTIVE ADVISORS LLC: Director
Holdings: 1,934,115 shares
Latest Transaction: May 29 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of PERCEPTIVE ADVISORS LLC in Lyra Therapeutics, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ACRX, ADMA, AGRX, ALBO, ALDX, FOLD, ARAV, ATNX, ATHA, CATB, CERE, CORI, CRNX, DOVA, GBT, KDMN, LJPC, LABP, LPTX, LYRA, MGTX, MOTS, RXDX, QTNT, RAIN, SCYX, SLDB, VBIV, VBIV, VRCA, MNLO, ZGNX
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 29 2020 | LYRA | Lyra Therapeutics, ... | PERCEPTIVE ADVISORS LLC | Director | Buy | P | 16.00 | 625,000 | 10,000,000 | 1,934,115 | 1.3 M to 1.9 M (+47.74 %) |
May 06 2020 | LYRA | Lyra Therapeutics, ... | PERCEPTIVE ADVISORS LLC | Director | Option Exercise | X | 8.63 | 339,604 | 2,930,783 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | PERCEPTIVE ADVISORS LLC | Director | Option Exercise | X | 8.63 | 141,221 | 1,218,737 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | PERCEPTIVE ADVISORS LLC | Director | Option Exercise | C | 0.00 | 16,232,511 | 0 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | PERCEPTIVE ADVISORS LLC | Director | Option Exercise | C | 0.00 | 39,035,325 | 0 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | PERCEPTIVE ADVISORS LLC | Director | Option Exercise | C | 0.00 | 26,666,666 | 0 | 0 | |
May 06 2020 | LYRA | Lyra Therapeutics, ... | PERCEPTIVE ADVISORS LLC | Director | Payment of Exercise | F | 16.00 | 183,174 | 2,930,784 | 1,288,446 | 1.5 M to 1.3 M (-12.45 %) |
May 06 2020 | LYRA | Lyra Therapeutics, ... | PERCEPTIVE ADVISORS LLC | Director | Buy | X | 8.63 | 339,604 | 2,930,783 | 1,471,620 | 1.1 M to 1.5 M (+30.00 %) |
May 06 2020 | LYRA | Lyra Therapeutics, ... | PERCEPTIVE ADVISORS LLC | Director | Payment of Exercise | F | 16.00 | 76,172 | 1,218,752 | 1,309,115 | 1.4 M to 1.3 M (-5.50 %) |
May 06 2020 | LYRA | Lyra Therapeutics, ... | PERCEPTIVE ADVISORS LLC | Director | Buy | X | 8.63 | 141,221 | 1,218,737 | 1,385,287 | 1.2 M to 1.4 M (+11.35 %) |
May 06 2020 | LYRA | Lyra Therapeutics, ... | PERCEPTIVE ADVISORS LLC | Director | Buy | C | 0.00 | 470,739 | 0 | 1,244,066 | 773.3 K to 1.2 M (+60.87 %) |
May 06 2020 | LYRA | Lyra Therapeutics, ... | PERCEPTIVE ADVISORS LLC | Director | Buy | C | 0.00 | 1,132,016 | 0 | 1,132,016 | 0 to 1.1 M |
May 06 2020 | LYRA | Lyra Therapeutics, ... | PERCEPTIVE ADVISORS LLC | Director | Buy | C | 0.00 | 773,327 | 0 | 773,327 | 0 to 773.3 K |
May 01 2020 | LYRA | Lyra Therapeutics, ... | PERCEPTIVE ADVISORS LLC | Director | Option Exercise | A | 16.00 | 14,500 | 232,000 | 14,500 | |
May 01 2020 | LYRA | Lyra Therapeutics, ... | PERCEPTIVE ADVISORS LLC | Director | Option Exercise | A | 16.00 | 14,500 | 232,000 | 14,500 | |
May 01 2020 | LYRA | Lyra Therapeutics, ... | PERCEPTIVE ADVISORS LLC | Director | Option Exercise | A | 16.00 | 14,500 | 232,000 | 14,500 | |
May 01 2020 | LYRA | Lyra Therapeutics, ... | PERCEPTIVE ADVISORS LLC | Director | Option Exercise | A | 16.00 | 14,500 | 232,000 | 14,500 |
Page: 1